cold corpse, page-4

Pfizer increasing its stake doesn't deliver a red cent to the company unless it's in the form of another capital raising, which PSD doesn't need right now. In any case, that would be outside the licence agreement. Assuming PSD didn't stuff up the deal, if Pfizer wants the technology they'll have to pay for it as per the agreement. Their only other option would be to walk away from the deal and launch a takeover, but I don't see how they'd buy the company for less than the full value of the agreement, since if they launch a takeover they would be effectively announcing that regard PSD's technology to be very valuable to them.

As the nothing happening so far. Six months is not long for work such as this, so I wouldn't be panicking about no news just yet.

Pezz